AI for Drug Discovery

Using artificial intelligence to help accelerate drug discovery, screening, development, and related pharmaceutical research.

LUX TAKE:

After many years of development and interest, major pharmaceutical companies are making more significant investments in AI and forging more and deeper relationships with startups. COVID-19 is also bringing these tools into the spotlight, as they are becoming critical in developing treatments and vaccines. The innovations coming out of these processes are being augmented and finding their way into ...

Lux Take last updated on April 24, 2020
Data last updated on February 26, 2021

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent AI for drug discovery developments.

New Lux Content

Menten AI (February 26, 2021)

Digital Transformation: Key Developments and Predictions for 2021 (February 3, 2021)

New Patents

Computing...

New Investment Rounds

Computing...

Related companies	Schrödinger, Deep Genomics, InsideDNA, Numerate, Atomwise, Deep 6 AI, Recursion Pharmaceuticals , Berg, Insilico Medicine, XtalPi, NuMedii, OWKIN, twoXAR, Cyclica, BioXcel Therapeutics, Verge Genomics, Exscientia, Globavir Biosciences, Engine Biosciences, Healx, Lantern Pharma, Standigm, Bioage Labs, e-Therapeutics, GTN, Mind the Byte, Quantitative Medicine, Linguamatics, BenevolentAI, Cyrus Biotechnology, Zymol

Related companies

Schrödinger, Deep Genomics, InsideDNA, Numerate, Atomwise, Deep 6 AI, Recursion Pharmaceuticals , Berg, Insilico Medicine, XtalPi, NuMedii, OWKIN, twoXAR, Cyclica, BioXcel Therapeutics, Verge Genomics, Exscientia, Globavir Biosciences, Engine Biosciences, Healx, Lantern Pharma, Standigm, Bioage Labs, e-Therapeutics, GTN, Mind the Byte, Quantitative Medicine, Linguamatics, BenevolentAI, Cyrus Biotechnology, Zymol

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978